EP2931249

COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS

  • Status:
    EP einkaleyfi: Þýðing ekki lögð inn
  • EP appl. date:
    13.12.2013
  • EP published:
    16.1.2019
  • EP application number:
    13803046.5
  • Max expiry date:
    12.12.2033
  • Title:
    COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS

Timeline

Today
13.12.2013EP application
16.1.2019EP Publication

Owner

  • Name:
    Glaxo Group Limited
  • Address:
    980 Great West Road Brentford, Middlesex TW8 9GS, GB

Inventor

  • Name:
    IGNAR, Diane Michele
  • Address:
    Research Triangle Park, North Carolina, US
  • Name:
    LEVIN, Daren Scott
  • Address:
    Research Triangle Park, North Carolina, US

Priority

  • Number:
    201261737927 P
  • Date:
    17.12.2012
  • Country:
    US
  • Number:
    201361867794 P
  • Date:
    20.8.2013
  • Country:
    US

Classification

  • Categories:
    A61K 31/451, A61K 31/58, A61K 9/00, A61K 9/10, A61K 47/38, A61K 47/26, A61P 11/02, A61P 27/14

Upload documents